These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 34290231)

  • 21. Alpha-6 integrin promotes radioresistance of glioblastoma by modulating DNA damage response and the transcription factor Zeb1.
    Kowalski-Chauvel A; Modesto A; Gouaze-Andersson V; Baricault L; Gilhodes J; Delmas C; Lemarie A; Toulas C; Cohen-Jonathan-Moyal E; Seva C
    Cell Death Dis; 2018 Aug; 9(9):872. PubMed ID: 30158599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BIRC3 is a novel driver of therapeutic resistance in Glioblastoma.
    Wang D; Berglund A; Kenchappa RS; Forsyth PA; Mulé JJ; Etame AB
    Sci Rep; 2016 Feb; 6():21710. PubMed ID: 26888114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitochondrial protein ATPase family, AAA domain containing 3A correlates with radioresistance in glioblastoma.
    You WC; Chiou SH; Huang CY; Chiang SF; Yang CL; Sudhakar JN; Lin TY; Chiang IP; Shen CC; Cheng WY; Lin JC; Shieh SH; Chow KC
    Neuro Oncol; 2013 Oct; 15(10):1342-52. PubMed ID: 24057885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genome-Wide CRISPR-Cas9 Screens Expose Genetic Vulnerabilities and Mechanisms of Temozolomide Sensitivity in Glioblastoma Stem Cells.
    MacLeod G; Bozek DA; Rajakulendran N; Monteiro V; Ahmadi M; Steinhart Z; Kushida MM; Yu H; Coutinho FJ; Cavalli FMG; Restall I; Hao X; Hart T; Luchman HA; Weiss S; Dirks PB; Angers S
    Cell Rep; 2019 Apr; 27(3):971-986.e9. PubMed ID: 30995489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Essential role of METTL3-mediated m
    Visvanathan A; Patil V; Arora A; Hegde AS; Arivazhagan A; Santosh V; Somasundaram K
    Oncogene; 2018 Jan; 37(4):522-533. PubMed ID: 28991227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RNA binding protein RBM14 promotes radio-resistance in glioblastoma by regulating DNA repair and cell differentiation.
    Yuan M; Eberhart CG; Kai M
    Oncotarget; 2014 May; 5(9):2820-6. PubMed ID: 24811242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FOXM1 and STAT3 interaction confers radioresistance in glioblastoma cells.
    Maachani UB; Shankavaram U; Kramp T; Tofilon PJ; Camphausen K; Tandle AT
    Oncotarget; 2016 Nov; 7(47):77365-77377. PubMed ID: 27764801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Engineered Extracellular Vesicle-Delivered CRISPR/Cas9 for Radiotherapy Sensitization of Glioblastoma.
    Liu X; Cao Z; Wang W; Zou C; Wang Y; Pan L; Jia B; Zhang K; Zhang W; Li W; Hao Q; Zhang Y; Zhang W; Xue X; Lin W; Li M; Gu J
    ACS Nano; 2023 Sep; 17(17):16432-16447. PubMed ID: 37646615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiotherapy resistance acquisition in Glioblastoma. Role of SOCS1 and SOCS3.
    Ventero MP; Fuentes-Baile M; Quereda C; Perez-Valeciano E; Alenda C; Garcia-Morales P; Esposito D; Dorado P; Manuel Barbera V; Saceda M
    PLoS One; 2019; 14(2):e0212581. PubMed ID: 30811476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytochrome c oxidase mediates labile iron level and radioresistance in glioblastoma.
    Ali MY; Oliva CR; Flor S; Goswami PC; Griguer CE
    Free Radic Biol Med; 2022 May; 185():25-35. PubMed ID: 35476930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. microRNAs: Potential glioblastoma radiosensitizer by targeting radiation-related molecular pathways.
    Bahreyni-Toossi MT; Dolat E; Khanbabaei H; Zafari N; Azimian H
    Mutat Res; 2019 Nov; 816-818():111679. PubMed ID: 31715522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CIS deletion by CRISPR/Cas9 enhances human primary natural killer cell functions against allogeneic glioblastoma.
    Nakazawa T; Morimoto T; Maeoka R; Matsuda R; Nakamura M; Nishimura F; Ouji N; Yamada S; Nakagawa I; Park YS; Ito T; Nakase H; Tsujimura T
    J Exp Clin Cancer Res; 2023 Aug; 42(1):205. PubMed ID: 37563692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-338-5p sensitizes glioblastoma cells to radiation through regulation of genes involved in DNA damage response.
    Besse A; Sana J; Lakomy R; Kren L; Fadrus P; Smrcka M; Hermanova M; Jancalek R; Reguli S; Lipina R; Svoboda M; Slampa P; Slaby O
    Tumour Biol; 2016 Jun; 37(6):7719-27. PubMed ID: 26692101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitochondrial glutamate transporter SLC25A22 uni-directionally export glutamate for metabolic rewiring in radioresistant glioblastoma.
    Shin E; Kim B; Kang H; Lee H; Park J; Kang J; Park E; Jo S; Kim HY; Lee JS; Lee JM; Youn H; Youn B
    Int J Biol Macromol; 2023 Dec; 253(Pt 8):127511. PubMed ID: 37866557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-155 acts as an anti-inflammatory factor in atherosclerosis-associated foam cell formation by repressing calcium-regulated heat stable protein 1.
    Li X; Kong D; Chen H; Liu S; Hu H; Wu T; Wang J; Chen W; Ning Y; Li Y; Lu Z
    Sci Rep; 2016 Feb; 6():21789. PubMed ID: 26899994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brahma-Related Gene-1 (BRG1) promotes the malignant phenotype of glioblastoma cells.
    Wang Y; Yang CH; Schultz AP; Sims MM; Miller DD; Pfeffer LM
    J Cell Mol Med; 2021 Mar; 25(6):2956-2966. PubMed ID: 33528916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ILKAP, ILK and PINCH1 control cell survival of p53-wildtype glioblastoma cells after irradiation.
    Hausmann C; Temme A; Cordes N; Eke I
    Oncotarget; 2015 Oct; 6(33):34592-605. PubMed ID: 26460618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genome-wide expression profiling of glioblastoma using a large combined cohort.
    Tang J; He D; Yang P; He J; Zhang Y
    Sci Rep; 2018 Oct; 8(1):15104. PubMed ID: 30305647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Upregulation of LGMNP1 confers radiotherapy resistance in glioblastoma.
    Xu H; Chen B; Xing J; Wei Z; Liu C; Qiu Y; Lin Y; Ren L
    Oncol Rep; 2019 Jun; 41(6):3435-3443. PubMed ID: 31002346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CRISPRi-based radiation modifier screen identifies long non-coding RNA therapeutic targets in glioma.
    Liu SJ; Malatesta M; Lien BV; Saha P; Thombare SS; Hong SJ; Pedraza L; Koontz M; Seo K; Horlbeck MA; He D; Birk HS; Jain M; Olsen HE; Akeson M; Weissman JS; Monje M; Gupta N; Raleigh DR; Ullian EM; Lim DA
    Genome Biol; 2020 Mar; 21(1):83. PubMed ID: 32234056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.